Effect of insulin therapy on endothelium-dependent dilation in type 2 diabetes mellitus.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Cardiology

• Publication date

  2002-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0002-9149(01)02266-4PMID 11835925
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved endothelial function with metformin in type 2 diabetes mellitus.

  2001cited by this paper
• Ascorbate Restores Endothelium-Dependent Vasodilation Impaired by Acute Hyperglycemia in Humans

  2001cited by this paper
• Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity

  2001cited by this paper
• Insulin therapy improves endothelial function in type 2 diabetes.

  2000cited by this paper
• Ciprofibrate therapy improves endothelial function and reduces postprandial lipemia and oxidative stress in type 2 diabetes mellitus.

  2000cited by this paper
• Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance.

  2000cited by this paper
• Impaired endothelium-dependent vasodilation in type 2 diabetes. Relation to LDL size, oxidized LDL, and antioxidants.

  1999cited by this paper
• Effect of oral vitamin E (α‐tocopherol) supplementation on vascular endothelial function in Type 2 diabetes mellitus

  1999cited by this paper
• C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992.

  1999cited by this paper
• Endothelium-dependent flow-mediated vasodilation in the postprandial state in type 2 diabetes mellitus.

  1999cited by this paper
• C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

  1999cited by this paper
• Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery.

  1999cited by this paper
• Novel inflammatory markers of coronary risk: theory versus practice.

  1999cited by this paper
• Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: an hypothesis.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Insulin and risk of cardiovascular disease: a meta-analysis.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Preserved Endothelial Function in IDDM Patients, but Not in NIDDM Patients, Compared With Healthy Subjects

  1998cited by this paper
• NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X

  1997cited by this paper
• Endothelial dysfunction and pathogenesis of diabetic angiopathy.

  1997cited by this paper
• Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus.

  1996cited by this paper
• Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia.

  1996cited by this paper
• Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor.

  1996cited by this paper
• Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor

  1996cited by this paper
• Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo.

  1995cited by this paper
• Lipid advanced glycosylation: pathway for lipid oxidation in vivo.

  1993cited by this paper
• Vascular Thrombosis in Type II Diabetes Mellitus

  1993cited by this paper
• Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

  1992cited by this paper
• Hemoglobin-AGE: a circulating marker of advanced glycosylation.

  1992cited by this paper
• Impaired endothelium-dependent and independent vasodilation in patients with Type 2 (non-insulin-dependent) diabetes mellitus

  1992cited by this paper
• Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications.

  1989cited by this paper

• Vascular function after acute aerobic exercise in adults with and without type 2 diabetes mellitus

  2025cites this paper
• ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETES MELLITUS AND ITS RELATION WITH GLYCAEMIC CONTROL- RESULTS OF AN OBSERVATIONAL STUDY

  2017cites this paper
• Postprandial Dysmetabolism and Oxidative Stress in Type 2 Diabetes: Pathogenetic Mechanisms and Therapeutic Strategies

  2015cites this paper
• Experimental study on apoptosis of TNFR1 receptor pro-endothelial progenitor cells activated by high glucose induced oxidative stress.

  2015cites this paper
• Endothelial Dysfunction and Dyslipidemia in Type 2 Diabetes: Pathogenesis, Significance and Therapy

  2014cites this paper
• The influence of fenofibrate on lipid profile, endothelial dysfunction, and inflammatory markers in type 2 diabetes mellitus patients with typical and mixed dyslipidemia.

  2013cites this paper
• Endothelial dysfunction in diabetes: pathogenesis, significance, and treatment.

  2013cites this paper
• Rosiglitazone improves endothelial function in patients with type 2 diabetes treated with insulin

  2011cites this paper
• Insulin Therapy does not Interfere with Venous Endothelial Function Evaluation in Patients with Type 2 Diabetes Mellitus

  2010cites this paper
• Impaired endothelial function and insulin action in first-degree relatives of patients with type 2 diabetes mellitus.

  2009cites this paper
• Influence of Visceral Obesity and Liver Fat on Vascular Structure and Function in Obese Subjects

  2009cites this paper
• Insulin glargine reduces carotid intimal hyperplasia after balloon catheter injury in Zucker fatty rats possibly by reduction in oxidative stress

  2009cites this paper
• Hypoglycemic pharmacological treatment of type 2 diabetes: targeting the endothelium.

  2009cites this paper
• Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease

  2008cites this paper
• Effects of Oral Glucose Load on Endothelial Function and on Insulin and Glucose Fluctuations in Healthy Individuals

  2008cites this paper
• Atividade das ectonucleotidases, colinesterase sérica e perfil oxidativo no diabetes melito tipo 2 e hipertensão em humanos

  2008cites this paper
• The Potential Beneficial Role of Glucagon-like Peptide-1 in Endothelial Dysfunction and Heart Failure Associated with Insulin Resistance

  2008cites this paper
• Papel do exercício físico na disfunção endotelial de pacientes com síndrome metabólica e Diabetes mellitus

  2007cites this paper
• Endothelial dysfunction in diabetes mellitus

  2007cites this paper
• Abnormal systolic blood pressure during treadmill test and brachial artery flow-mediated vasodilatation impairment.

  2007cites this paper
• Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus

  2007influential citation
• Pharmacodynamic effects of orally administered dexlipotam on endothelial function in type 2-diabetic patients.

  2007cites this paper
• The role of angiotensin II type 1 receptor blockers in the prevention and management of diabetes mellitus

  2007cites this paper
• [Augmentation of myocardial function by improved glycemic control in patients with type 2 diabetes mellitus].

  2007cites this paper
• Positive family history of coronary artery disease is associated with reduced myocardial vasoreactivity in healthy men.

  2006cites this paper
• Pioglitazone Restores Endothelial Function in Patients with Type 2 Diabetes Treated with Insulin

  2006cites this paper
• Insulin Therapy, Glycemic Control, and Cardiovascular Risk Factors in Young Latin Americans with Type 2 Diabetes Mellitus

  2006cites this paper
• Correction of Endothelial Dysfunction in Diabetic Female Rats by Tetrahydrobiopterin and Chronic Insulin

  2006cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL - UFRGS FACULDADE DE MEDICINA HOSPITAL DE CLÍNICAS DE PORTO ALEGRE - HCPA PROGRAMA DE PÓS-GRADUACAO EM CIÊNCIAS DA SAÚDE:

  2006cites this paper
• The metabolic syndrome: Effects of a pronounced weight loss induced by bariatric surgery

  2005cites this paper
• Mechanisms, Significance and Treatment of Vascular Dysfunction in Type 2 Diabetes Mellitus

  2005cites this paper
• Hyperglycemia Reduces Survival and Impairs Function of Circulating Blood-Derived Progenitor Cells

  2005cites this paper
• Dysregulation of the endothelial nitric oxide synthase-soluble guanylate cyclase pathway is normalized by insulin in the aorta of diabetic rat.

  2005cites this paper
• Metabolic syndrome and endothelial dysfunction

  2005cites this paper
• Obesity and diabetes as risk factors for coronary artery disease: from the epidemiological aspect to the initial vascular mechanisms

  2005cites this paper
• Nontraditional risk factors for cardiovascular disease in diabetes.

  2004cites this paper
• The Role of Exercise in the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes Mellitus

  2004cites this paper
• Glargine and Regular Human Insulin Similarly Acutely Enhance Endothelium-Dependent Vasodilatation in Normal Subjects

  2004cites this paper
• The postprandial state does not impair endothelial function in women with Type 2 diabetes irrespective of glycaemic control

  2004cites this paper
• Management of diabetes and hyperglycemia in hospitals.

  2004cites this paper
• Disfunção endotelial na resistência à insulina e diabetes melito : efeitos do exercício

  2004cites this paper
• Insulin Is an Anti-inflammatory and Anti-atherosclerotic Hormone

  2004cites this paper
• Insulin resistance and endothelial dysfunction.

  2003cites this paper
• Novel cardiovascular risk factors and macrovascular and microvascular complications of diabetes.

  2003cites this paper
• PPARγ Agonists and Vascular Risk Factors: Potential Effects on Cardiovascular Disease

  2003cites this paper
• Obstetric and gynaecological anaesthesia

  2003cites this paper
• Early detection of vascular disease in Type 2 Diabetes

  2003cites this paper
• Insulin and myocardial blood flow.

  2003cites this paper
• Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus

  2003cites this paper
• Factors affecting progression of renal failure in patients with type 2 diabetes.

  2003cites this paper
• Insulin as an anti-inflammatory and antiatherosclerotic hormone.

  2003cites this paper
• Restoration of Endothelial Function by Increasing High‐Density Lipoprotein in Subjects With Isolated Low High‐Density Lipoprotein

  2003cites this paper
• Augmentation index as a measure of peripheral vascular disease state.

  2002cites this paper
• Vascular reactivity in diabetes mellitus

  2002influential citation
• Effects of thiazolidinediones on cardiovascular risk factors

  2002cites this paper
• Endothelium-dependent dilatation in patients with type 2 diabetes.

  2002cites this paper